Long Term Rehabilitation Centers, Long Term Drug Treatment Facilities, Alcohol Treatment Centers
Long term rehabilitation centers, long term drug treatment facilities, alcohol treatment centers – The Fall 2010 International Treatment Center’s Cooperative Conference held in Vero Beach, Florida co-sponsored by Southworth Associates and The Gonzalez Recovery Residences was a sold out two day affair. The conference is designed to help some of the top treatment centers connect andnetwork. In attendance were the admissions, medical, treatment, discharge planning clinicians and marketing personnel of some of the leading organizations in the addiction treatment field. A variety of interventionists, detox centers, inpatient drug rehab facilities, Long term rehabilitation centers, long term drug treatment facilities, and long term alcohol treatment centers attended the two days of informal networking and formal presentation opportunities with the other attendees. During the formal presentation, the attending organizations highlighted three distinguishing features of, and recent developments to, their respective Programs. Attendees enjoyed meals and networking opportunities. ITCC Video 1 10-17-2010
Increased interest in pot dispensaries
Filed under: inpatient drug rehab centers
The law also calls for 35 medical marijuana treatment centers across the state's 14 counties, at least one but no more than five in every county. One of the biggest concerns is how the production and sale of the drug will be regulated. The Department …
Read more on WWLP 22News
A satisfactory measure? Studies show focus on keeping patients happy can …
Filed under: inpatient drug rehab centers
That prospective cohort study of nearly 52,000 patients and the care they received concluded that higher patient satisfaction was associated with greater inpatient care use, higher overall healthcare and prescription drug spending and increased mortality.
Read more on ModernHealthcare.com
Dexpramipexole Fails in ALS
Filed under: inpatient drug rehab centers
"We share the disappointment of members of the ALS community, who had hoped that dexpramipexole would offer a meaningful treatment option," Douglas E. Williams, PhD, executive vice president of research and development at Biogen Idec, said in the …
Read more on Medscape